Hospi

About:

Hospi provides patient-centric products that Improve quality of life.

Website: http://hospicorp.com/

Top Investors: National Science Foundation, The Angels' Forum

Description:

Hospi Corporation improves the quality of life by innovating practical, high impact medical devices that enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost. Its patient-centric focus is informed by a nursing perspective and has guided the development of Hospi’s first product, the Macy Catheter®, which has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available in the United States. The Macy Catheter was invented by Hospi co-founder Brad Macy, a 20-year hospice nurse veteran, who leveraged his experience to address the need for a product to help improve patient comfort and wellbeing. The Macy Catheter is a simple, patented, and innovative medical device designed to facilitate discreet and comfortable rectal administration of liquids or medications. The rectal route of administration is relevant, yet underutilized, in the hospice, palliative care, and home health settings. It is particularly useful for the management of symptoms when a patient has difficulty swallowing or the oral route is otherwise compromised.

Total Funding Amount:

$4.76M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newark, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)hospicorp.com

Founders:

Brad Macy, Igal Ladabaum, Richard Popp

Number of Employees:

11-50

Last Funding Date:

2020-05-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai